Table VI.
Pathway | Nominal P-value | Matched entities | Pathway entities |
---|---|---|---|
Hs calcium regulation in the cardiac cell WP536-75219a | 0.00002112 | 2 | 150 |
Hs MAPK cascade WP422 −72129a | 0.00002112 | 2 | 29 |
Hs inflammatory response pathway WP453-63217 | 0.00002112 | 2 | 33 |
Hs focal adhesion WP306-71714a | 0.00002112 | 2 | 188 |
Hs myometrial relaxation and contraction pathways WP289-72107a | 0.004421 | 4 | 156 |
Hs GPCRs, Class C Metabotropic glutamate, pheromone WP501-63205 | 0.004632 | 1 | 15 |
Hs Regulation of toll like receptor signaling pathway WP1449-72114 | 0.004632 | 1 | 150 |
Hs Toll-like receptor signaling pathway WP75-72133 | 0.004632 | 1 | 102 |
Hs IL-1 signaling pathway WP195-74010 | 0.004632 | 1 | 55 |
Hs Wnt signaling pathway and pluripotency WP399-74897a | 0.004632 | 1 | 100 |
Hs JAK STAT WP2593-74127a | 0.004632 | 1 | 44 |
Hs MAPK signaling pathway WP382-72103a | 0.009645 | 3 | 168 |
Hs Apoptosis Modulation and Signaling WP1772-63162 | 0.009645 | 3 | 93 |
Hs apoptosis WP254-72110a | 0.009645 | 3 | 84 |
Hs GPCRs, class A rhodopsin-like WP455-74420a | 0.009645 | 3 | 261 |
Pathways are common pathway in villous sample and maternal plasma sample obtained from pathway analysis. Matched entities, genes targeted by dysregulated miRNA; Pathway entities, total number of genes in the pathway.